{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:25:13Z","timestamp":1779110713232,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.autrev.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T16:46:55Z","timestamp":1504975615000},"page":"1115-1118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Should we treat congenital heart block with fluorinated corticosteroids?"],"prefix":"10.1016","volume":"16","author":[{"given":"Antonio","family":"Brucato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Ramoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.09.005_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zeron","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9149(86)90064-0","article-title":"Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies","volume":"58","author":"Ho","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0015","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.09.005_bb0020","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.20554","article-title":"Outcome of pregnancies in patients with anti-SSA\/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.09.005_bb0025","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.09.005_bb0030","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0735-1097(10)80148-2","article-title":"Perinatal outcome of fetal complete atrioventricular block: a multicenter experience","volume":"17","author":"Schmidt","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0035","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.09.005_bb0040","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.09.005_bb0045","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.autrev.2015.08.005","article-title":"Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome","volume":"14","author":"Levesque","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.09.005_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/eje.0.1440087","article-title":"Clinical implications of glucocorticoid metabolism by 11 beta-hydroxysteroid dehydrogenases in target tissues","volume":"144","author":"Quinkler","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ncprheum1018","article-title":"Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside","volume":"5","author":"Buyon JPm Clancy","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0060","first-page":"689","article-title":"A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone","volume":"92","author":"Rosenthal","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0065","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.09.005_bb0070","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.09.005_bb0075","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0080","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.107.735118","article-title":"Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution","volume":"118","author":"Lopes","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.09.005_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2016.09.119","article-title":"Fluorinated steroids do not improve outcome of isolated atrioventricular block","volume":"225","author":"Van den Berg","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0090","first-page":"373","article-title":"Primary Sj\u00f6gren's syndrome\u2014treatment of fetal incomplete atrioventricular block with dexamethasone","volume":"28","author":"Theander","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.061267","article-title":"Ineffective therapy, underpowered studies, or merely too little, too late? Risk factors and impact of maternal corticosteroid treatment on outcome in antibody-associated fetal heart block","volume":"124","author":"Pike","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.09.005_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune-associated congenital heart block","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.autrev.2017.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2015-208311","article-title":"Assessment of fluorinated steroids to avert progression and mortality in anti-SSA\/Ro-associated cardiac injury limited to the fetal conduction system","volume":"75","author":"Izmirly","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.09.005_bb0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.09.005_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-1-1","article-title":"The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs","volume":"1","author":"Barrington","year":"2001","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.autrev.2017.09.005_bb0125","first-page":"S703","article-title":"Critical management decisions in cardiac neonatal lupus: the role of fluorinated steroids","volume":"64","author":"Izmirly","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.09.005_bb0130","first-page":"706","article-title":"Plasmapheresis, intravenous immunoglobulins and betamethasone\u2014a combined protocol to treat autoimmune congenital heart block: a prospective cohort study","volume":"34","author":"Ruffatti","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2017.09.005_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.09.005_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.09.005_bb0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721730229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721730229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T20:36:38Z","timestamp":1535402198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721730229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S156899721730229X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.09.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should we treat congenital heart block with fluorinated corticosteroids?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}